Screener
Upstream Bio, Inc. UPB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
FAQ
- What is Upstream Bio, Inc.'s total liabilities?
- Upstream Bio, Inc. (UPB) reported total liabilities of $10.21M in Q2 2026.
- How has Upstream Bio, Inc.'s total liabilities changed year-over-year?
- Upstream Bio, Inc.'s total liabilities decreased by 13.3% year-over-year, from $11.78M to $10.21M.
- What is the long-term trend for Upstream Bio, Inc.'s total liabilities?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s total liabilities has grown at a 22.1% compound annual growth rate (CAGR), from $9.39M to $14M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Upstream Bio, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude